Sterilizing System utilizes electron beam.
Share:
Press Release Summary:
Suitable for sterilizing sensitive materials and complex products, SmartDose™ provides controls for simultaneous variable dose distribution, simultaneous dual beam redundancy, uninterrupted temperature controls, and intelligent tooling. Applications include allograft tissue, biomaterials, advanced polymers, drugs/biologics, and hydrogels as well as Teflon, implantables, bioabsorbables, bioresorbables, and combination devices.
Original Press Release:
Groundbreaking Innovation for Sterilizing Medical Devices and Pharmaceuticals using Electron Beam
Nutek Corporation develops SmartDose™ system for sterilizing sensitive materials and combination medical devices
HAYWARD, CA – As a response to some of the fastest growing, but most under-served, segments in the healthcare industry, Nutek Corporation (www.NutekCorp.com), Â an R&D innovation center and high-volume contract sterilizer for the medical device, pharmaceutical, and other industries has developed a groundbreaking system, called SmartDose™, for sterilizing sensitive materials and complex products with E-beam (Electron Beam).
SmartDose™ provides options and efficiencies for sterilization that have never been accomplished before, such as providing different doses… to different places… on the same product… at the same time… even while controlling temperatures throughout the entire process. Traditional methods, processes, tooling, and freezers fail to provide the intelligence of SmartDose™, which has an even more profound effect on complex combination products, as well as traditionally challenging materials that are irradiation and heat sensitive.
SmartDose™ increases sterilization success by up to 67% by reducing costly product re-designs, providing significant project time savings, and decreasing production waste by up to 40%. Simply put, the net effect of SmartDose™ is the ability of manufacturers to get products to market quicker and more cost effectively than ever before.
“Traditional methods of sterilization focus on high-volume throughput, freezers, and packaging configurations - at this point, almost all of the contract sterilizers in the U.S. do these pretty well”, said Larry Nichols, COO of Nutek. “SmartDose™ leaps several steps beyond what has ever been done before by utilizing an actual design specific to the products and materials, from drug filled stents to Teflon coated devices. We even have a customer in Europe that couldn’t get their product sterilized with any of the modalities, including E-beam, Ethylene Oxide, and Gamma… until SmartDose™.”
SmartDose™ is the only system in the industry to provide controls for simultaneous variable dose distribution, simultaneous dual beam redundancy, uninterrupted temperature controls, and intelligent tooling. Because SmartDose™ results in quicker irradiation success, tighter dose ranges, and the highest throughput available in the industry, customers save time, money, and release products to market faster. Applications eligible for SmartDose™ include allograft tissue, biomaterials, advanced polymers, drugs/biologics, hydrogels, Teflon, implantables, bioabsorbables, bioresorbables, and combination devices.
About NUTEK Corporation
Nutek Corporation (www.NutekCorp.com) was founded in 1990 as a small irradiation facility and has grown into a world class R&D innovation center and high-volume contract sterilizer that provides ondemand sterilization, microbiology, crosslinking, and expert consultative services to the medical device, biopharma, health care product, and other industries by utilizing Electron Beam technology and Sterilization by Design™. Nutek provides consulting services at no cost as part of its standard service, demonstrating an exceptional level of commitment to its customers. Nutek is the developer of SmartDose™, the only system in the industry to provide controls for simultaneous variable dose distribution, simultaneous dual beam redundancy, uninterrupted temperature controls, and intelligent tooling. Because SmartDose™ results in quicker irradiation success, tighter dose ranges, and the highest throughput available in the industry, customers save time, money, and release products to market faster. Applications eligible for SmartDose™ include allograft tissue, biomaterials, advanced polymers, drugs/biologics, hydrogels, Teflon, implantables, bioabsorbables, bioresorbables, and combination devices.
To view case studies of Nutek’s customers, CLICK HERE.
Jeff Sauter
510-429-2900
Jeff@NutekCorp.com
Nutek Corporation
1001 Whipple Road
Hayward, CA 94544
www.NutekCorp.com
